New oxygen device could make throat surgery safer

NCT ID NCT03472118

Terminated Symptom relief Sponsor: CMC Ambroise Paré Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device that delivers high-flow oxygen through the nose during throat surgery. The goal was to keep patients' oxygen levels safe without using a breathing tube. The trial included 29 adults in two French hospitals. The device was considered safe if blood oxygen stayed above 95% and no serious complications occurred.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nasal High Flow Oxygen (Optiflow device)
What this could lead to: If successful, this device could offer a safer way to deliver oxygen during throat surgeries, avoiding the need for a breathing tube.
What could go wrong: The trial was terminated early with only 29 participants, so results are limited. The technique may fail if oxygen levels drop, and there is a risk of carbon dioxide buildup.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acidosis, Respiratory Apnea laryngeal disorder sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA APNEA LARYNGOSCOPY

Contacts and locations

Locations

Hôpital Foch

Suresnes, Île-de-France Region, 92151, France
Hôpital René Huguenin - Institut Curie

Saint-Cloud, Île-de-France Region, 92310, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.